Business Case Studies, Mergers, Acquisitions and Takeovers Case Study, Ranbaxy's Acquisition of Terapia,Creation of the Largest Generic Company of Romania

print page
Tell A Friend
Bookmark
 

Case Categories

Mergers, Acquisitions and Takeovers Case Study

IBS CDC IBS CDC IBS CDC IBS CDC RSS Feed
Case Title:

Ranbaxy's Acquisition of Terapia: Creation of the Largest Generic Company of Romania

Publication Year : 2006

Authors: Satyakama Paul, Snehasish Chowdhary

Industry: Health Care

Region:Romania

Case Code: MAA0083K

Teaching Note: Not Available

Structured Assignment: Not Available

Buy This Case Study
OR





Abstract:

In March 29, 2006, Ranbaxy Laboratories Limited, the leading pharmaceutical and generic drug company of India, announced that it would acquire Terapia, the largest independent generic company of Romania. Ranbaxy announced that it would acquire 96.7% of Terapia at USD 324 million from its parent investing company, Advent International. The deal, expected to be completed within the second quarter of 2006, was valuable for Ranbaxy. With the US generic market gradually shrinking, a number of governmental regulations to be adhered to, and the price erosion in the market, Ranbaxy had to shift its focus to Europe. With a considerable foothold over the country’s generic market, Ranbaxy intended to cross the threshold of the other high growth generics markets of Europe.

The case focuses on Ranbaxy’s inorganic growth strategies and the various market factors that it considered while entering the lucrative generic market of Romania. It also provides a brief description of the US, European and the Romanian generic market. Such information, coupled with the company backgrounds of the two companies, would help in analysing Ranbaxy’s chances of establishing a strong foothold over the Romanian and subsequently the European generic market.

Pedagogical Objectives:

  • To discuss the European Generic pharmaceutical market
  • To discuss Ranbaxy’s inorganic growth strategies and the various market factors that it considered while entering the lucrative generic market of Romania
  • To discuss the possible synergies and challenges of the acquisition.

Keywords : Mergers,Acquisitions,Alliances Case Study;Ranbaxy Laboratories Limited; Terapia SA; Romanian generic market; European generic market; US generic market; US FDA (United States Federal Drug Administration); Integrated distribution network; Low cost clinical trials; Para IV filing; Bio equivalence; Merger and acquisition; Inorganic growth strategy; Product portfolio; Work culture

Contents : 
Ranbaxy Laboratories Limited
Synergies Of The Acquisition
The Global Sales Figure Of Ranbaxy
The Distribution Network Of Terapia
The Generics Market Potental Of Romania

Recently Bought Case Studies

    Recently Bought Case Studies

    Executive Interviews

  • Dr James O` TooleDr James O` Toole

    Dr James O` Toole, Daniels Distinguished Professor of Business Ethics at the University of Denver’s Daniels College of Business
    Speaks on The Making of a CEO
  • Paul BrackenPaul Bracken

    Prof. Paul Bracken, leading expert in global competition and the strategic application of technology in business and defense.
    Speaks on Midlife Crisis
  • Bill FischerBill Fischer

    Bill Fischer, Professor of Technology, IMD
    Speaks on Building High Performance Teams
  • View All Executive Interviews»





Contact us: IBS Case Development Centre (IBSCDC), IFHE Campus, Donthanapally, Sankarapally Road, Hyderabad-501203, Telangana, INDIA.
Mob: +91- 9640901313,
E-mail: casehelpdesk@ibsindia.org

©2020 - 25 IBS Case Development Centre. All rights reserved. | Careers | Privacy Policy | Terms of Use | Disclosure | Site Map xml sitemap